BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29620255)

  • 1. Different splicing isoforms of ERCC1 affect the expression of its overlapping genes CD3EAP and PPP1R13L, and indicate a potential application in non-small cell lung cancer treatment.
    Zhang G; Xue P; Cui S; Yu T; Xiao M; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X
    Int J Oncol; 2018 Jun; 52(6):2155-2165. PubMed ID: 29620255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.
    Yin J; Vogel U; Ma Y; Wang H; Wang C; Liang D; Yue L; Ma J; Li X
    Lung Cancer; 2012 Jun; 76(3):286-91. PubMed ID: 22335888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression.
    Yu T; Xue P; Cui S; Zhang L; Zhang G; Xiao M; Zheng X; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X
    Cancer Med; 2018 Dec; 7(12):6317-6330. PubMed ID: 30453383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-mapping markers of lung cancer susceptibility in a sub-region of chromosome 19q13.3 among Chinese.
    Yin J; Wang H; Vogel U; Wang C; Ma Y; Hou W; Zhang Y; Guo L; Li X
    Oncotarget; 2016 Sep; 7(38):60929-60939. PubMed ID: 27183913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.
    Yin J; Wang H; Vogel U; Wang C; Hou W; Ma Y
    Tumour Biol; 2016 Apr; 37(4):5467-73. PubMed ID: 26563375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Polymorphisms in XRCC1, CD3EAP, PPP1R13L, XPB, XPC, and XPF and the Risk of Chronic Benzene Poisoning in a Chinese Occupational Population.
    Xue P; Gao L; Xiao S; Zhang G; Xiao M; Zhang Q; Zheng X; Cai Y; Jin C; Yang J; Wu S; Lu X
    PLoS One; 2015; 10(12):e0144458. PubMed ID: 26681190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Repair Genes ERCC1 and BRCA1 Expression in Non-Small Cell Lung Cancer Chemotherapy Drug Resistance.
    Wang S; Liu F; Zhu J; Chen P; Liu H; Liu Q; Han J
    Med Sci Monit; 2016 Jun; 22():1999-2005. PubMed ID: 27289442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative PDGF/PDGFR and focal adhesion pathways are downregulated in ERCC1-defective non-small cell lung cancer undergoing sodium glycididazole-sensitized cisplatin treatment.
    He L; Wang X; Liu K; Wu X; Yang X; Song G; Zhang B; Zhong L
    Gene; 2019 Apr; 691():70-76. PubMed ID: 30584903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLTSCR1, ATM, PPP1R13L and CD3EAP Genetic Variants and Lung Cancer Risk in a Chinese Population.
    Yin JY; Ma YG; Vogel U; Liu DH; Sun ZX
    Curr Med Sci; 2018 Aug; 38(4):734-740. PubMed ID: 30128886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hapmap-based evaluation of ERCC2, PPP1R13L, and ERCC1 and lung cancer risk in a Chinese population.
    Yin J; Vogel U; Wang C; Liang D; Ma Y; Wang H; Yue L; Liu D; Ma J; Sun X
    Environ Mol Mutagen; 2012 Apr; 53(3):239-45. PubMed ID: 22351191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19p13.3-GADD45B common variants and 19q13.3-PPP1R13L and 19q13.3-CD3EAP in lung cancer risk among Chinese.
    Hou W; Yin J; Vogel U; Sun Z; Liang D
    Chem Biol Interact; 2017 Nov; 277():74-78. PubMed ID: 28870783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR exon 19-deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non-small cell lung cancer.
    Zhang L; Pradhan B; Guo L; Meng F; Zhong D
    Thorac Cancer; 2020 Feb; 11(2):277-285. PubMed ID: 31875360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PPP1R13L and CD3EAP variants on lung cancer susceptibility among nonsmoking Chinese women.
    Yin J; Guo L; Wang C; Wang H; Ma Y; Liu J; Liang D; Ma J; Zhao Y
    Gene; 2013 Jul; 524(2):228-31. PubMed ID: 23624123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer.
    Wang S; Pan H; Liu D; Mao N; Zuo C; Li L; Xie T; Huang D; Huang Y; Pan Q; Yang L; Wu J
    Int J Oncol; 2015 Feb; 46(2):809-17. PubMed ID: 25434755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impacts of ERCC1 gene exon VIII alternative splicing on cisplatin-resistance in ovarian cancer cells.
    Sun Y; Li T; Ma K; Tian Z; Zhu Y; Chen F; Hu G
    Cancer Invest; 2009 Nov; 27(9):891-7. PubMed ID: 19832035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.
    Friboulet L; Barrios-Gonzales D; Commo F; Olaussen KA; Vagner S; Adam J; Goubar A; Dorvault N; Lazar V; Job B; Besse B; Validire P; Girard P; Lacroix L; Hasmats J; Dufour F; André F; Soria JC
    Clin Cancer Res; 2011 Sep; 17(17):5562-72. PubMed ID: 21750204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.
    Tsai MS; Weng SH; Chen HJ; Chiu YF; Huang YC; Tseng SC; Kuo YH; Lin YW
    Mol Cancer Ther; 2012 Mar; 11(3):561-71. PubMed ID: 22053010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
    Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
    Vilmar A; Sørensen JB
    Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.
    He L; Liu K; Wang X; Chen H; Zhou J; Wu X; Liu T; Yang Y; Yang X; Cui D; Song G; Wang J; Lei J
    Int J Biochem Cell Biol; 2018 Jul; 100():54-60. PubMed ID: 29768183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.